SCHEMBL57683

SCHEMBL57683

CCC(=Cc1ccccc1)C(=O)O

nearest known ligand 0.63

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 1/20 0.63
CYP2C9 P11712 1/20 0.63
RECQL P46063 1/20 0.56
AKR1C3 P42330 1/20 0.55
TBXAS1 P24557 2/20 0.55
MEN1 O00255 1/20 0.52
KMT2A Q03164 1/20 0.52
EPHX2 P34913 2/20 0.50
PPARG P37231 1/20 0.50
AKR1C1 Q04828 1/20 0.48
LMNA P02545 1/20 0.47
TDP1 Q9NUW8 1/20 0.46
HTT P42858 1/20 0.46
ALDH1A1 P00352 1/20 0.45
TSHR P16473 1/20 0.45
MME P08473 2/20 0.45
NR1I2 O75469 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL309762 1.00 CYP3A4 (0.63) CYP3A4CYP2C9RECQLAKR1C3TBXAS1
SCHEMBL2918640 1.00 CYP3A4 (0.63) CYP3A4CYP2C9RECQLAKR1C3TBXAS1
SCHEMBL5173409 0.91 TBXAS1 (0.58) CYP3A4CYP2C9RECQLAKR1C3TBXAS1
Methacrylic Acid SCHEMBL10714804 0.91 CYP3A4 (0.54) CYP3A4CYP2C9RECQLAKR1C3TBXAS1
Oxirane SCHEMBL15646744 0.91 CYP3A4 (0.54) CYP3A4CYP2C9RECQLAKR1C3TBXAS1
SCHEMBL9061442 0.89 TP53 (0.59) CYP3A4CYP2C9RECQLAKR1C3TBXAS1
SCHEMBL15955486 0.88 CYP3A4 (0.55) CYP3A4CYP2C9RECQLAKR1C3TBXAS1
SCHEMBL15955485 0.88 CYP3A4 (0.55) CYP3A4CYP2C9RECQLAKR1C3TBXAS1
SCHEMBL5007835 0.88 CYP3A4 (0.51) CYP3A4CYP2C9RECQLAKR1C3TBXAS1
SCHEMBL30752458 0.86 RECQL (0.70) CYP3A4CYP2C9RECQLAKR1C3TBXAS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 724 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4426105-B1 COCOA PLANT CELL CULTURE PROCESSING METHODS AND PRODUCTS OBTAINED BY THE SAME ZHAW ZUERCHER HOCHSCHULE FUER ANGEWANDTE WSS (CH) 2026-04-29 EP claimed
US-20250352444-A1 Antimicrobial mixtures SYMRISE AG (DE) 2025-11-20 US claimed
EP-4609167-A1 COMPOSITION AND METHOD FOR CLEARING BIOLOGICAL SAMPLES Centre National de la Recherche Scientifique (FR) 2025-09-03 EP claimed
EP-4525822-A1 ANTIMICROBIAL MIXTURES Symrise AG (DE) 2025-03-26 EP claimed
EP-4255208-B1 CHOCOLATE REPLICAS PRODUCED FROM INDIVIDUAL COMPONENTS VOYAGE FOODS INC (US) 2024-12-25 EP claimed
EP-3930472-B1 COFFEE REPLICAS PRODUCED FROM INDIVIDUAL COMPONENTS VOYAGE FOODS INC (US) 2024-09-11 EP claimed
WO-2024089224-A1 COMPOSITION AND METHOD FOR CLEARING BIOLOGICAL SAMPLES CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) 2024-05-02 WO claimed
EP-3548890-B1 MEANS AND METHODS FOR VISUALIZATION OF TISSUE STRUCTURES GRETZ NORBERT (DE) 2024-03-27 EP claimed
EP-4297900-A2 CONTAINER FOR A SAMPLE AND METHOD FOR EXAMINING A SAMPLE WITH THE CONTAINER Paul Marienfeld GmbH & Co. KG (DE) 2024-01-03 EP claimed
US-20230383163-A1 COOLING LIQUID COMPOSITION FOR ELECTRIC VEHICLE KD FINECHEM CO., LTD. (KR) 2023-11-30 US claimed
EP-0831870-A1 USE OF ESSENTIAL OILS TO INCREASE BIOAVAILABILITY OF ORAL PHARMACEUTICAL COMPOUNDS Avmax, Inc. (US) 1998-04-01 EP claimed
US-5716928-A ADMINISTERING DRUG CONCURRENTLY WITH ESSENTIAL OIL AVMAX, INC. (US) 1998-02-10 US claimed
WO-1997045568-A1 ZINC PHOSPHATING WITH INTEGRATED SUBSEQUENT PASSIVATION HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) 1997-12-04 WO claimed
US-5665386-A Use of essential oils to increase bioavailability of oral pharmaceutical compounds AVMAX, INC. (US) 1997-09-09 US claimed
US-5610249-A FREE RADICAL CATALYST, ORGANIC PHOSPHORUS COMPOUND KANSAI PAINT CO., LTD. (JP) 1997-03-11 US claimed
WO-1996040192-A1 USE OF ESSENTIAL OILS TO INCREASE BIOAVAILABILITY OF ORAL PHARMACEUTICAL COMPOUNDS AVMAX, INC. (US) 1996-12-19 WO claimed
EP-0319016-B1 Treatment and after-treatment of metal with polyphenol compounds HENKEL CORP (US) 1994-06-22 EP claimed
EP-0319017-B1 Treatment and after-treatment of metal with carbohydrate-modified polyphenol compounds HENKEL CORP (US) 1994-04-13 EP claimed
EP-0166542-A2 Triterpenyl esters of organic acids, process for their production, and hypolipidemic agents composed of them AMANO PHARMACEUTICAL CO., LTD. (JP) 1986-01-02 EP claimed
EP-0009041-B1 PROCESS FOR PREPARING AROMATIC AMIDE ANTIOXIDANTS THE GOODYEAR TIRE & RUBBER COMPANY (US) 1982-10-06 EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250352444-A1 Antimicrobial mixtures LRBA, MGLL, TAS2R50 CYP3A4 2500/4885CYP2C9 3901/4885RECQL 1921/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.